Verition Fund Management
HUMA icon

Verition Fund Management’s Humacyte HUMA Stock Holding History

Verition Fund Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60,505
Closed -$103K – 3739
2025
Q1 		$103K Buy
+60,505
New +$227K ﹤0.01% 3150
2024
Q4 		– Sell
-90,240
Closed -$491K – 3352
2024
Q3 		$491K Buy
90,240
+74,101
+459% +$489K ﹤0.01% 2339
2024
Q2 		$77.5K Buy
+16,139
New +$84K ﹤0.01% 2759
2023
Q4 		– Sell
-39,356
Closed -$115K – 2492
2023
Q3 		$115K Buy
+39,356
New +$130K ﹤0.01% 2099
2021
Q3 		– Sell
-30,000
Closed -$306K – 2089
2021
Q2 		$306K Hold
30,000
– – ﹤0.01% 1334
2021
Q1 		$325K Buy
+30,000
New +$328K ﹤0.01% 1078

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Verition Fund Management's HUMA Position: Q2 2025 in Review

Verition Fund Management sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 60,505 shares — an estimated $103K sold.

Verition Fund Management first reported a position in HUMA in Q1 2021 and held it in 6 quarters. The position peaked at $491K in Q3 2024. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Verition Fund Management reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 60,505 Humacyte shares in Q2 2025, an estimated $103K.
  • Verition Fund Management first reported a position in Humacyte in Q1 2021 and held it in 6 quarters.
  • Verition Fund Management's Humacyte position peaked at $491K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.